| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bifidobacterium adolescentis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bifidobacterium longum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bifidobacterium ruminatum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Collinsella intestinalis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Collinsella intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eggerthella lenta co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eggerthella lenta co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[2], [3] |
| Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [5], [6] |
| Bacteria: Bacteroidetes |
| Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Alistipes indistinctus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Alistipes indistinctus co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Alistipes indistinctus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides caccae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides cellulosilyticus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides dorei co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides eggerthii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides eggerthii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides eggerthii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides finegoldii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [14], [15] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides fragilis co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides ovatus co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides sartorii co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides stercoris co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides stercoris co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 8 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) metabolizes the drug Irinotecan hydrochloride, and Bacteroides thetaiotaomicron further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[], [16] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides thetaiotaomicron co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides uniformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) metabolizes the drug Irinotecan hydrochloride, and Bacteroides uniformis further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[], [16] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Verapamil hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1681
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Verapamil hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[17], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides vulgatus co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 10 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacteroides xylanisolvens co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Odoribacter splanchnicus co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 6 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Phenytoin |
Click to Show/Hide the Detail |
| Drug ID |
DR1282
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug Phenytoin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[11], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides distasonis co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides johnsonii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides johnsonii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides merdae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides merdae co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Prevotella copri co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Bacteria: Firmicutes |
| Anaerobutyricum hallii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerobutyricum hallii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Anaerococcus hydrogenalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerococcus hydrogenalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Anaerostipes hadrus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerostipes hadrus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Imatinib mesylate |
Click to Show/Hide the Detail |
| Drug ID |
DR0858
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerostipes hadrus co-metabolize the drug Imatinib mesylate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Anaerotruncus colihominis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerotruncus colihominis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Anaerotruncus colihominis co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Buspirone |
Click to Show/Hide the Detail |
| Drug ID |
DR0248
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacillus megaterium co-metabolize the drug Buspirone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [18], [19] |
| Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
| Drug ID |
DR0476
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[2], [18] |
| Progesterone |
Click to Show/Hide the Detail |
| Drug ID |
DR1346
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[20], [19] |
| Propranolol hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR1367
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacillus megaterium co-metabolize the drug Propranolol hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[21], [19] |
| Testosterone cypionate |
Click to Show/Hide the Detail |
| Drug ID |
DR1564
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[4], [19], [22] |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia hansenii co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Blautia luti (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Blautia luti co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Clostridioides difficile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridioides difficile co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridioides difficile co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 9 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Nateglinide |
Click to Show/Hide the Detail |
| Drug ID |
DR1132
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Nateglinide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Nevirapine |
Click to Show/Hide the Detail |
| Drug ID |
DR1142
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Nevirapine, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Sildenafil citrate |
Click to Show/Hide the Detail |
| Drug ID |
DR1481
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Sildenafil citrate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Zaleplon |
Click to Show/Hide the Detail |
| Drug ID |
DR1725
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium botulinum co-metabolize the drug Zaleplon, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Clostridium leptum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium leptum co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [25] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) metabolizes the drug Irinotecan hydrochloride, and Clostridium perfringens further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[], [26] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [27] |
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium perfringens co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [27] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium perfringens co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [25] |
| Clostridium scindens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium scindens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dexamethasone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR0451
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium scindens co-metabolize the drug Dexamethasone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[10], [1] |
| Clostridium spiroforme (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium spiroforme co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Clostridium sporogenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium sporogenes co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium sporogenes co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [25] |
| Zonisamide |
Click to Show/Hide the Detail |
| Drug ID |
DR1737
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium sporogenes co-metabolize the drug Zonisamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[28], [29] |
| Clostridium symbiosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Clostridium symbiosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Coprococcus comes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Coprococcus comes co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Dorea formicigenerans (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Dorea formicigenerans co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterocloster asparagiformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Enterocloster bolteae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterocloster bolteae co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterocloster bolteae co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Enterococcus casseliflavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterococcus casseliflavus co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [30] |
| Enterococcus gallinarum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterococcus gallinarum co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [30] |
| Erysipelatoclostridium ramosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Erysipelatoclostridium ramosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Eubacterium cellulosolvens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0077922 |
Click to Show/Hide the Detail |
| Drug ID |
DR0786
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eubacterium cellulosolvens co-metabolize the drug BRN-0077922, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [32] |
| Eubacterium oxidoreducens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eubacterium oxidoreducens co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [25] |
| Eubacterium rectale (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eubacterium rectale co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Eubacterium ventriosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Eubacterium ventriosum co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 3 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Holdemanella biformis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Cyclophosphamide |
Click to Show/Hide the Detail |
| Drug ID |
DR0391
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Holdemanella biformis co-metabolize the drug Cyclophosphamide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[7], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Hungatella hathewayi co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Lactobacillus sakei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Erythromycin stearate |
Click to Show/Hide the Detail |
| Drug ID |
DR0614
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Lactobacillus sakei co-metabolize the drug Erythromycin stearate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[23], [33], [34] |
| Marvinbryantia formatexigens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Marvinbryantia formatexigens co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Mediterraneibacter glycyrrhizinilyticus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0077922 |
Click to Show/Hide the Detail |
| Drug ID |
DR0786
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Mediterraneibacter glycyrrhizinilyticus co-metabolize the drug BRN-0077922, which can collectively affect efficacy, safety or bioavailability of this drug. |
[31], [35] |
| Roseburia intestinalis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Roseburia intestinalis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Ruminococcus gnavus co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Ruminococcus lactaris (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Ruminococcus lactaris co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Streptococcus agalactiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) metabolizes the drug Irinotecan hydrochloride, and Streptococcus agalactiae further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[], [26] |
| Subdoligranulum variabile (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Subdoligranulum variabile co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Bacteria: Lentisphaerae |
| Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| BRN-0498823 |
Click to Show/Hide the Detail |
| Drug ID |
DR1167
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Victivallis vadensis co-metabolize the drug BRN-0498823, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Diltiazem hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0509
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Victivallis vadensis co-metabolize the drug Diltiazem hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[8], [1] |
| Bacteria: Proteobacteria |
| Enterobacter cloacae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Enterobacter cloacae co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [36] |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 5 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) metabolizes the drug Irinotecan hydrochloride, and Escherichia coli further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[], [37] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Escherichia coli co-metabolize the drug Irinotecan hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [37] |
| Norethindrone acetate |
Click to Show/Hide the Detail |
| Drug ID |
DR1750
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[9], [1] |
| Paclitaxel |
Click to Show/Hide the Detail |
| Drug ID |
DR1227
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Escherichia coli co-metabolize the drug Paclitaxel, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Ritonavir |
Click to Show/Hide the Detail |
| Drug ID |
DR1430
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Escherichia coli co-metabolize the drug Ritonavir, which can collectively affect efficacy, safety or bioavailability of this drug. |
[12], [1] |
| Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aztreonam |
Click to Show/Hide the Detail |
| Drug ID |
DR0169
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Klebsiella pneumoniae co-metabolize the drug Aztreonam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [39] |
| Klebsiella variicola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Aztreonam |
Click to Show/Hide the Detail |
| Drug ID |
DR0169
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Klebsiella variicola co-metabolize the drug Aztreonam, which can collectively affect efficacy, safety or bioavailability of this drug. |
[38], [40] |
| Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| RO-7-0207 |
Click to Show/Hide the Detail |
| Drug ID |
DR1204
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Salmonella enterica co-metabolize the drug RO-7-0207, which can collectively affect efficacy, safety or bioavailability of this drug. |
[24], [41] |
| Bacteria: Verrucomicrobia |
| Akkermansia muciniphila (verrucomicrobiae) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Finasteride |
Click to Show/Hide the Detail |
| Drug ID |
DR0695
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Akkermansia muciniphila co-metabolize the drug Finasteride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Pimozide |
Click to Show/Hide the Detail |
| Drug ID |
DR1291
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Akkermansia muciniphila co-metabolize the drug Pimozide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[], [1] |
| Amoebozoa: Evosea |
| Entamoeba histolytica (eukaryotes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Entamoeba histolytica co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [42] |
| Metamonada: Fornicata |
| Giardia intestinalis (diplomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Giardia intestinalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [42] |
| Metamonada: Parabasalia |
| Trichomonas vaginalis (trichomonads) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Metronidazole |
Click to Show/Hide the Detail |
| Drug ID |
DR1073
Drug Info
|
| Interaction Mechanism |
Human Cytochrome P450 3A7 (CYP3A7) and Trichomonas vaginalis co-metabolize the drug Metronidazole, which can collectively affect efficacy, safety or bioavailability of this drug. |
[13], [42] |
|
|
|
|
|
|